BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming January 5, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN INSPIRE MEDICAL SYSTEMS, INC. (INSP), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO.

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming January 12, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN) securities between October 22, 2024 and October 28, 2025, inclusive (the “Class Period”). Stride investors have until January 12, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN STRIDE, INC. (LRN), CO.

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed on behalf of purchasers or acquirers of Six Flags Entertainment Corporation f/k/a CopperSteel HoldCo, Inc. (NYSE: FUN) common stock pursuant or traceable to the company's registration statement and prospectus issued in connection with the July 1, 2024 merger of legacy Six Flags Entertainment Corporation (“Legacy Six Flags”) with Cedar Fair, L.P. (“Cedar Fair”), and their subsidiaries and affiliates (the “Merger”).

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Firefly Aerospace Inc. (“Firefly” or “the Company”) (NYSE: FLY) and certain of its officers.

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Stride, Inc. (“Stride” or “the Company”) (NYSE: LRN) and certain of its officers.

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Synopsys, Inc. (“Synopsys” or “the Company”) (NASDAQ: SNPS) and certain of its officers.

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Freeport-McMoRan Inc. (“Freeport” or “the Company”) (NYSE: FCX) and certain of its officers.

CALGARY, AB , Nov. 17, 2025 /PRNewswire/ - Canadian Pacific Kansas City (TSX: CP) (NYSE: CP) (CPKC) has named G3 Canada Limited and Bartlett Grain Company as the recipients of its annual Elevator of the Year awards for the 2024-2025 crop year. These awards, granted annually to one Canadian and one U.S. facility, highlight top performance in safety and efficiency among grain industry partners.

Gibraltar Industries, Inc. ( ROCK ) M&A Call November 17, 2025 8:30 AM EST Company Participants William Bosway - Chairman of the Board, President & CEO Joseph Lovechio - VP & Chief Financial Officer Conference Call Participants Carolyn Capaccio - Alliance Advisors, LLC Will Gildea - CJS Securities, Inc. Julio Romero - Sidoti & Company, LLC Walter Liptak - Seaport Research Partners Kathryn Thompson - Thompson Research Group, LLC Presentation Operator Greetings, and welcome to the Gibraltar Industries' Acquisition of OmniMax International Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.

Regeneron Pharmaceuticals, Inc. ( REGN ) 7th Annual Wolfe Research Healthcare Conference November 17, 2025 9:20 AM EST Company Participants Mark Hudson - Investor Relations Executive Isreal Lowy - Senior Vice President of Clinical Development Unit Head & Oncology Justin Holko Conference Call Participants Alexandria Hammond - Wolfe Research, LLC Presentation Alexandria Hammond Wolfe Research, LLC Good morning, everybody. My name is Alex Hammond, and I'm the senior biopharma analyst here at Wolfe Research.

NRx Pharmaceuticals, Inc. ( NRXP ) Q3 2025 Earnings Call November 17, 2025 8:30 AM EST Company Participants Matthew Duffy - Chief Business Officer & Co-CEO of Hope Therapeutics Michael Abrams - Chief Financial Officer Jonathan Javitt - Co-Founder, Chief Scientist Officer, Chairman & Interim CEO Conference Call Participants Thomas Shrader - BTIG, LLC, Research Division Patrick Trucchio - H.C. Wainwright & Co, LLC, Research Division Edward Woo - Ascendiant Capital Markets LLC, Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals' Q3 2025 Earnings Conference Call.

Sinclair is eyeing a takeover of its local media rival, but Scripps may not be ready to sell just yet.

FREUDENSTADT, Germany, Nov. 17, 2025 (GLOBE NEWSWIRE) -- On November 12, 2025, SCHMID Group N.V. ("SCHMID" or the “Company”) received a staff determination letter (the “Determination Letter”) from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”).

The shares of Alphabet Inc (NASDAQ: GOOGL) are trading up 5.1% at $290.37 at last check, moving higher after Warren Buffett's Berkshire Hathaway (BRK.A) said it bought 17.85 million shares -- valued at $4.93 billion -- from the Google parent during the third quarter.

Ford is now selling certified pre-owned vehicles on Amazon. Customers can browse, buy, and sign paperwork for cars at dealers within a 75-mile radius.

I reiterate my cautious buy rating on Advanced Micro Devices, Inc. after the company beat expectations in Q3. My thesis rests on the data center business and the 6 GW OpenAI MI450 deal. Q3 2025 showed broad-based momentum: record $9.25B revenue (+36% YOY), 22% data center growth, and outsized client (+46%) and gaming (2.8x) strength. I believe AMD's expanding AI PC roadmap (2.5x portfolio since 2024, Gorgon/Medusa targeting up to 10x AI performance) and rising AI PC penetration can support sustained client-side upside.

Digital innovation has long been viewed as a panacea for complexity. Across global logistics, that panacea, in the form of digital booking and payments solutions, is increasingly under pressure to deliver.

Johnson & Johnson (NYSE:JNJ) announced that it has entered into a definitive agreement to acquire Halda Therapeutics, a clinical-stage biotechnology company focused on developing targeted oral therapies for solid tumors, for $3.05 billion in cash. Halda's lead candidate, HLD-0915, is a once-daily oral therapy for prostate cancer that received FDA fast track designation in August 2025 following positive preliminary data from Phase 1/2 trials.

LNG sees U.S. liquefied natural gas demand surging as global buyers grow and capacity expands, but warns of price volatility, rising costs and contract risks.

LOS ANGELES, Nov. 17, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Baxter International Inc. (“Baxter” or “the Company”) (NYSE: BAX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before December 15, 2025.